- This test measures two specific biomarkers in the blood, typically used in prenatal screening to assess the risk of chromosomal abnormalities in the fetus, such as Down syndrome.
- This test evaluates three biomarkers in the blood to assess the risk of certain genetic conditions during pregnancy. It is commonly used to screen for Down syndrome, trisomy 18, and neural tube defects.
- This expanded test includes four biomarkers and provides a more comprehensive assessment of the risk for chromosomal abnormalities and birth defects during pregnancy, improving diagnostic accuracy compared to double or triple marker tests.
- CA 125 is a protein that may be elevated in women with ovarian cancer or other conditions affecting the ovaries. It is used to monitor disease progression or response to treatment.
- Beta-Human Chorionic Gonadotropin (Beta HCG) is a hormone produced during pregnancy. Elevated levels can confirm pregnancy, while abnormal levels may indicate issues such as ectopic pregnancy or gestational trophoblastic disease.
- This test is used for monitoring and diagnosing specific bacterial infections, particularly those that cause systemic reactions. It is helpful in detecting and managing conditions related to infections.
- CEA is a protein that may be elevated in various cancers, including colorectal cancer. It is used to monitor the effectiveness of cancer treatment and detect cancer recurrence.
Want to book this service? Fill out the contact form, and we'll get back to you as soon as possible!
Since our start, we’ve provided advanced diagnostics, compassionate care, and expert analysis to ensure top-quality results for countless patients.
Contact Us